Advertisement
Advertisement
BNGO
Bionano Genomics, Inc. Common Stock
1.52
USDSponsored
+0.02
+1.67%
Dec 31, 15:59 UTC -5
Closed
After-Market
1.52
0.00
-0.33%
BNGO Earnings Reports
Positive Surprise Ratio
BNGO beat 10 of 29 last estimates.
34%
Next Report
Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
$7.94M
/-$1.43
Implied change from Q3 25 (Revenue/ EPS)
+7.81%
/-10.06%
Implied change from Q4 24 (Revenue/ EPS)
-2.71%
/-90.97%
Bionano Genomics, Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, BNGO reported earnings of -1.59 USD per share (EPS) for Q3 25, beating the estimate of -1.94 USD, resulting in a 18.39% surprise. Revenue reached 7.37 million, compared to an expected 7.01 million, with a 5.12% difference. The market reacted with a +3.40% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -1.43 USD, with revenue projected to reach 7.94 million USD, implying an decrease of -10.06% EPS, and increase of 7.81% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
Dec 22, 2025 For Q4 25
Estimate
-$0.57
Actual
-$0.73
Surprise
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
Dec 19, 2025 For Q4 25
Estimate
-$0.25
Actual
-$0.19
Surprise
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
What were Bionano Genomics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bionano Genomics, Inc. Common Stock reported EPS of -$1.59, beating estimates by 18.39%, and revenue of $7.37M, 5.12% above expectations.
How did the market react to Bionano Genomics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.4%, changed from $1.47 before the earnings release to $1.52 the day after.
When is Bionano Genomics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 30, 2026.
What are the forecasts for Bionano Genomics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Bionano Genomics, Inc. Common Stock is expected to report EPS of -$1.43 and revenue of $7.94M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement